SAN DIEGO, CA (Oct. 8, 2014)—Suneva Medical, Inc., a privately-held aesthetics company, today announced the appointment of Peter Barton Hutt as a member of its Board of Directors. Known in the legal community as the “dean of the food and drug bar,” Mr. Hutt has been a leading food and drug law practitioner and scholar for half a century. Mr. Hutt has specialized in food and drug law at the Washington D.C. firm of Covington and Burling since 1960, pausing only to serve as Chief Counsel of the FDA from 1971 to 1975. A prodigious writer, he is co-author of the Food and Drug Law: Cases and Materials. He has also taught Food and Drug Law at Harvard Law School since 1994.
“Peter is one of the world’s leading attorneys concerning FDA matters, and an expert in U.S. health policy. We are thrilled that he has joined Suneva Medical’s Board of Directors,” said Nicholas L. Teti, Jr., Chairman and CEO of Suneva Medical. “As a director, his regulatory perspective and knowledge of the health care industry will be invaluable as we advance Suneva Medical’s broad product pipeline.”
Mr. Hutt is a member of the Institute of Medicine of the National Academy of Sciences, and serves on a wide variety of academic and scientific advisory boards and on the Board of Directors of several companies. In addition, he has represented the national trade associations for the food, prescription drug, nonprescription drug, dietary supplement, and cosmetic industries. While at the FDA he drafted the legislation that became the Medical Device Amendments of 1976, and beginning in 1962 he has participated in the drafting of most of the major legislation amending the Federal Food, Drug, and Cosmetic Act. He has testified before the House and Senate more than 100 times either as a witness or as counsel accompanying a witness.
Mr. Hutt received his B.A., magna cum laude, from Yale University, his LL.B. from Harvard University, and his LL.M. from New York University.
Media interested in speaking with a Suneva Medical representative should contact Melody Demel at 619-234-0345 or email@example.com.
About Suneva Medical, Inc.
Suneva Medical, Inc. is a privately-held aesthetics company focused on developing, manufacturing and commercializing novel, differentiated products for the general dermatology and aesthetic markets. The company currently markets ArteFill® in the U.S., Korea and Singapore; ReFissa® and Regenica® in the U.S. and Bellafill® in Canada. For more information, visit www.sunevamedical.com/old.